Raymond James lowers Welltower stock price target on valuation
Raymond James lowered Welltower's (WELL) price target to $263 from $270 but kept an Outperform rating. The firm raised its 2026-2028 FFO estimates, citing strong operational momentum. WELL's Q3 2026 earnings missed estimates, but revenue exceeded expectations. The stock trades at a P/E of 101, with some analysts noting overvaluation. UBS maintained a Buy rating with a $269 target.
How this was made
The 30-second read
Why it matters
Analyst target reduction may prompt short‑term selling pressure, but the unchanged rating and strong cash flow outlook could support the stock.
Market read
Provides fresh analyst guidance that could influence short‑term trading in WELL.
What to watch
Strong FFO growth and dividend continuity could offset the modest EPS miss.
Background
Raymond James updated its 2026‑2028 FFO outlook and maintained an Outperform rating despite the EPS miss.
Ticker impact
Raymond James lowered its price target on Welltower to $263 from $270 after the company's Q3 2026 earnings miss on EPS.
likely pressure as the market prices in the lower target
The target reduction is a fresh analyst action following earnings, indicating weaker expectations.
Market effects
May weigh on other senior‑housing REITs as valuation concerns rise.
Limited to U.S. REIT sector.
Low
Counterpoint
The Outperform rating remains, suggesting upside potential if the market overreacts to the target cut.
Key entities
- companyWelltower, Inc.
Senior housing REIT
- analystRaymond James
Equity research firm issuing the target change
